Dietrich C, Bartsch T, Schanz F, Oesch F, Wieser R J
Institute of Toxicology, Mainz, Germany.
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10815-9. doi: 10.1073/pnas.93.20.10815.
Proteases are known to play important roles in cell growth control, although the underlying mechanisms are still poorly understood. Here we show that the protease inhibitor N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal induced cell cycle arrest in platelet-derived growth factor-stimulated human fibroblasts at the G1/S boundary of the cell cycle by inhibiting the proteasome. Inhibition of the proteasome resulted in accumulation of the tumor suppressor p53, which was followed by an increase in the amount of the cyclin-dependent kinase-inhibitor p21. As a consequence, both phosphorylation and activity of the cyclin-dependent kinase 2/cyclin E complex were inhibited. We further observed that the retinoblastoma gene product, pRb, remained in the hypophosphorylated state, thus preventing cells from progression into the S-phase. These studies strongly support the hypothesis that the proteasome is a key regulator in the G1-phase of cell cycle progression.
蛋白酶在细胞生长控制中发挥重要作用,尽管其潜在机制仍知之甚少。在此我们表明,蛋白酶抑制剂N - 乙酰 - L - 亮氨酰 - L - 亮氨酰 - L - 正亮氨酸通过抑制蛋白酶体,在血小板衍生生长因子刺激的人成纤维细胞中,诱导细胞周期在细胞周期的G1/S边界处停滞。蛋白酶体的抑制导致肿瘤抑制因子p53的积累,随后细胞周期蛋白依赖性激酶抑制剂p21的量增加。结果,细胞周期蛋白依赖性激酶2/细胞周期蛋白E复合物的磷酸化和活性均受到抑制。我们进一步观察到,视网膜母细胞瘤基因产物pRb保持低磷酸化状态,从而阻止细胞进入S期。这些研究有力地支持了蛋白酶体是细胞周期G1期进展的关键调节因子这一假说。